Ci Investments Inc. Fate Therapeutics Inc Transaction History

Ci Investments Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$4.24 - $11.12 $165 - $433	-39 Reduced 1.27%	3,043 $17,000
Q4 2022 Feb 10, 2023	BUY	$9.86 - $23.83 $24,472 - $59,146	2,482 Added 413.67%	3,082 $31,000
Q3 2022 Nov 14, 2022	SELL	$21.04 - $36.06 $925 - $1,586	-44 Reduced 6.83%	600 $13,000
Q2 2022 Aug 12, 2022	BUY	$17.78 - $42.39 $3,200 - $7,630	180 Added 38.79%	644 $16,000
Q1 2022 May 12, 2022	BUY	$29.67 - $60.28 $13,648 - $27,728	460 Added 11500.0%	464 $18,000
Q3 2021 Nov 12, 2021	BUY	$59.27 - $95.73 $237 - $382	4 New	4 $0

176

113M

53.7K

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $136M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

Get notified when there are updates to the investment portfolio of Ci Investments Inc., based on Form 13F filings with the SEC.

Stay updated on Ci Investments Inc. with notifications on news.